Global Recombinant Plasma Protein Therapeutics Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Recombinant Plasma Protein Therapeutics Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Recombinant Plasma Protein Therapeutics by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Recombinant Plasma Protein Therapeutics by Country/Region, 2017, 2022 & 2028

2.2 Recombinant Plasma Protein Therapeutics Segment by Type

2.2.1 Recombinant Coagulation Factors

2.2.2 Human C1 Esterase Inhibitor

2.3 Recombinant Plasma Protein Therapeutics Sales by Type

2.3.1 Global Recombinant Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)

2.3.2 Global Recombinant Plasma Protein Therapeutics Revenue and Market Share by Type (2017-2022)

2.3.3 Global Recombinant Plasma Protein Therapeutics Sale Price by Type (2017-2022)

2.4 Recombinant Plasma Protein Therapeutics Segment by Application

2.4.1 Hemophilia A

2.4.2 Hemophilia B

2.4.3 Von Willebrand Disease

2.5 Recombinant Plasma Protein Therapeutics Sales by Application

2.5.1 Global Recombinant Plasma Protein Therapeutics Sale Market Share by Application (2017-2022)

2.5.2 Global Recombinant Plasma Protein Therapeutics Revenue and Market Share by Application (2017-2022)

2.5.3 Global Recombinant Plasma Protein Therapeutics Sale Price by Application (2017-2022)

3 Global Recombinant Plasma Protein Therapeutics by Company

3.1 Global Recombinant Plasma Protein Therapeutics Breakdown Data by Company

3.1.1 Global Recombinant Plasma Protein Therapeutics Annual Sales by Company (2020-2022)

3.1.2 Global Recombinant Plasma Protein Therapeutics Sales Market Share by Company (2020-2022)

3.2 Global Recombinant Plasma Protein Therapeutics Annual Revenue by Company (2020-2022)

3.2.1 Global Recombinant Plasma Protein Therapeutics Revenue by Company (2020-2022)

3.2.2 Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Company (2020-2022)

3.3 Global Recombinant Plasma Protein Therapeutics Sale Price by Company

3.4 Key Manufacturers Recombinant Plasma Protein Therapeutics Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Recombinant Plasma Protein Therapeutics Product Location Distribution

3.4.2 Players Recombinant Plasma Protein Therapeutics Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Recombinant Plasma Protein Therapeutics by Geographic Region

4.1 World Historic Recombinant Plasma Protein Therapeutics Market Size by Geographic Region (2017-2022)

4.1.1 Global Recombinant Plasma Protein Therapeutics Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Recombinant Plasma Protein Therapeutics Annual Revenue by Geographic Region

4.2 World Historic Recombinant Plasma Protein Therapeutics Market Size by Country/Region (2017-2022)

4.2.1 Global Recombinant Plasma Protein Therapeutics Annual Sales by Country/Region (2017-2022)

4.2.2 Global Recombinant Plasma Protein Therapeutics Annual Revenue by Country/Region

4.3 Americas Recombinant Plasma Protein Therapeutics Sales Growth

4.4 APAC Recombinant Plasma Protein Therapeutics Sales Growth

4.5 Europe Recombinant Plasma Protein Therapeutics Sales Growth

4.6 Middle East & Africa Recombinant Plasma Protein Therapeutics Sales Growth

5 Americas

5.1 Americas Recombinant Plasma Protein Therapeutics Sales by Country

5.1.1 Americas Recombinant Plasma Protein Therapeutics Sales by Country (2017-2022)

5.1.2 Americas Recombinant Plasma Protein Therapeutics Revenue by Country (2017-2022)

5.2 Americas Recombinant Plasma Protein Therapeutics Sales by Type

5.3 Americas Recombinant Plasma Protein Therapeutics Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Recombinant Plasma Protein Therapeutics Sales by Region

6.1.1 APAC Recombinant Plasma Protein Therapeutics Sales by Region (2017-2022)

6.1.2 APAC Recombinant Plasma Protein Therapeutics Revenue by Region (2017-2022)

6.2 APAC Recombinant Plasma Protein Therapeutics Sales by Type

6.3 APAC Recombinant Plasma Protein Therapeutics Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Recombinant Plasma Protein Therapeutics by Country

7.1.1 Europe Recombinant Plasma Protein Therapeutics Sales by Country (2017-2022)

7.1.2 Europe Recombinant Plasma Protein Therapeutics Revenue by Country (2017-2022)

7.2 Europe Recombinant Plasma Protein Therapeutics Sales by Type

7.3 Europe Recombinant Plasma Protein Therapeutics Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Recombinant Plasma Protein Therapeutics by Country

8.1.1 Middle East & Africa Recombinant Plasma Protein Therapeutics Sales by Country (2017-2022)

8.1.2 Middle East & Africa Recombinant Plasma Protein Therapeutics Revenue by Country (2017-2022)

8.2 Middle East & Africa Recombinant Plasma Protein Therapeutics Sales by Type

8.3 Middle East & Africa Recombinant Plasma Protein Therapeutics Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Recombinant Plasma Protein Therapeutics

10.3 Manufacturing Process Analysis of Recombinant Plasma Protein Therapeutics

10.4 Industry Chain Structure of Recombinant Plasma Protein Therapeutics

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Recombinant Plasma Protein Therapeutics Distributors

11.3 Recombinant Plasma Protein Therapeutics Customer

12 World Forecast Review for Recombinant Plasma Protein Therapeutics by Geographic Region

12.1 Global Recombinant Plasma Protein Therapeutics Market Size Forecast by Region

12.1.1 Global Recombinant Plasma Protein Therapeutics Forecast by Region (2023-2028)

12.1.2 Global Recombinant Plasma Protein Therapeutics Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Recombinant Plasma Protein Therapeutics Forecast by Type

12.7 Global Recombinant Plasma Protein Therapeutics Forecast by Application

13 Key Players Analysis

13.1 CSL Limited

13.1.1 CSL Limited Company Information

13.1.2 CSL Limited Recombinant Plasma Protein Therapeutics Product Offered

13.1.3 CSL Limited Recombinant Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 CSL Limited Main Business Overview

13.1.5 CSL Limited Latest Developments

13.2 Takeda

13.2.1 Takeda Company Information

13.2.2 Takeda Recombinant Plasma Protein Therapeutics Product Offered

13.2.3 Takeda Recombinant Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Takeda Main Business Overview

13.2.5 Takeda Latest Developments

13.3 Octapharma

13.3.1 Octapharma Company Information

13.3.2 Octapharma Recombinant Plasma Protein Therapeutics Product Offered

13.3.3 Octapharma Recombinant Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Octapharma Main Business Overview

13.3.5 Octapharma Latest Developments

13.4 Novo Nordisk A/S

13.4.1 Novo Nordisk A/S Company Information

13.4.2 Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Product Offered

13.4.3 Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Novo Nordisk A/S Main Business Overview

13.4.5 Novo Nordisk A/S Latest Developments

13.5 Pfizer

13.5.1 Pfizer Company Information

13.5.2 Pfizer Recombinant Plasma Protein Therapeutics Product Offered

13.5.3 Pfizer Recombinant Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Pfizer Main Business Overview

13.5.5 Pfizer Latest Developments

13.6 Bioverativ Therapeutics

13.6.1 Bioverativ Therapeutics Company Information

13.6.2 Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Product Offered

13.6.3 Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bioverativ Therapeutics Main Business Overview

13.6.5 Bioverativ Therapeutics Latest Developments

13.7 Aptevo Therapeutics

13.7.1 Aptevo Therapeutics Company Information

13.7.2 Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Product Offered

13.7.3 Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Aptevo Therapeutics Main Business Overview

13.7.5 Aptevo Therapeutics Latest Developments

13.8 Pharming Group

13.8.1 Pharming Group Company Information

13.8.2 Pharming Group Recombinant Plasma Protein Therapeutics Product Offered

13.8.3 Pharming Group Recombinant Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Pharming Group Main Business Overview

13.8.5 Pharming Group Latest Developments

14 Research Findings and Conclusion

Table 1. Recombinant Plasma Protein Therapeutics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Recombinant Plasma Protein Therapeutics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Recombinant Coagulation Factors

Table 4. Major Players of Human C1 Esterase Inhibitor

Table 5. Global Recombinant Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)

Table 6. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)

Table 7. Global Recombinant Plasma Protein Therapeutics Revenue by Type (2017-2022) & ($ million)

Table 8. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Type (2017-2022)

Table 9. Global Recombinant Plasma Protein Therapeutics Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Recombinant Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)

Table 11. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)

Table 12. Global Recombinant Plasma Protein Therapeutics Revenue by Application (2017-2022)

Table 13. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Application (2017-2022)

Table 14. Global Recombinant Plasma Protein Therapeutics Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Recombinant Plasma Protein Therapeutics Sales by Company (2020-2022) & (K Units)

Table 16. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Company (2020-2022)

Table 17. Global Recombinant Plasma Protein Therapeutics Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Company (2020-2022)

Table 19. Global Recombinant Plasma Protein Therapeutics Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Recombinant Plasma Protein Therapeutics Producing Area Distribution and Sales Area

Table 21. Players Recombinant Plasma Protein Therapeutics Products Offered

Table 22. Recombinant Plasma Protein Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Recombinant Plasma Protein Therapeutics Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Recombinant Plasma Protein Therapeutics Sales Market Share Geographic Region (2017-2022)

Table 27. Global Recombinant Plasma Protein Therapeutics Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Recombinant Plasma Protein Therapeutics Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Country/Region (2017-2022)

Table 31. Global Recombinant Plasma Protein Therapeutics Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Recombinant Plasma Protein Therapeutics Sales by Country (2017-2022) & (K Units)

Table 34. Americas Recombinant Plasma Protein Therapeutics Sales Market Share by Country (2017-2022)

Table 35. Americas Recombinant Plasma Protein Therapeutics Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Recombinant Plasma Protein Therapeutics Revenue Market Share by Country (2017-2022)

Table 37. Americas Recombinant Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)

Table 38. Americas Recombinant Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)

Table 39. Americas Recombinant Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)

Table 40. Americas Recombinant Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)

Table 41. APAC Recombinant Plasma Protein Therapeutics Sales by Region (2017-2022) & (K Units)

Table 42. APAC Recombinant Plasma Protein Therapeutics Sales Market Share by Region (2017-2022)

Table 43. APAC Recombinant Plasma Protein Therapeutics Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Recombinant Plasma Protein Therapeutics Revenue Market Share by Region (2017-2022)

Table 45. APAC Recombinant Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)

Table 46. APAC Recombinant Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)

Table 47. APAC Recombinant Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)

Table 48. APAC Recombinant Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)

Table 49. Europe Recombinant Plasma Protein Therapeutics Sales by Country (2017-2022) & (K Units)

Table 50. Europe Recombinant Plasma Protein Therapeutics Sales Market Share by Country (2017-2022)

Table 51. Europe Recombinant Plasma Protein Therapeutics Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Recombinant Plasma Protein Therapeutics Revenue Market Share by Country (2017-2022)

Table 53. Europe Recombinant Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)

Table 54. Europe Recombinant Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)

Table 55. Europe Recombinant Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)

Table 56. Europe Recombinant Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Recombinant Plasma Protein Therapeutics Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Recombinant Plasma Protein Therapeutics Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Recombinant Plasma Protein Therapeutics Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Recombinant Plasma Protein Therapeutics Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Recombinant Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Recombinant Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Recombinant Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Recombinant Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Recombinant Plasma Protein Therapeutics

Table 66. Key Market Challenges & Risks of Recombinant Plasma Protein Therapeutics

Table 67. Key Industry Trends of Recombinant Plasma Protein Therapeutics

Table 68. Recombinant Plasma Protein Therapeutics Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Recombinant Plasma Protein Therapeutics Distributors List

Table 71. Recombinant Plasma Protein Therapeutics Customer List

Table 72. Global Recombinant Plasma Protein Therapeutics Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Recombinant Plasma Protein Therapeutics Sales Market Forecast by Region

Table 74. Global Recombinant Plasma Protein Therapeutics Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Recombinant Plasma Protein Therapeutics Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Recombinant Plasma Protein Therapeutics Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Recombinant Plasma Protein Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Recombinant Plasma Protein Therapeutics Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Recombinant Plasma Protein Therapeutics Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Recombinant Plasma Protein Therapeutics Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Recombinant Plasma Protein Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Recombinant Plasma Protein Therapeutics Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Recombinant Plasma Protein Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Recombinant Plasma Protein Therapeutics Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Recombinant Plasma Protein Therapeutics Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Recombinant Plasma Protein Therapeutics Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Recombinant Plasma Protein Therapeutics Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Recombinant Plasma Protein Therapeutics Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Recombinant Plasma Protein Therapeutics Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Recombinant Plasma Protein Therapeutics Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Recombinant Plasma Protein Therapeutics Revenue Market Share Forecast by Application (2023-2028)

Table 92. CSL Limited Basic Information, Recombinant Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 93. CSL Limited Recombinant Plasma Protein Therapeutics Product Offered

Table 94. CSL Limited Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. CSL Limited Main Business

Table 96. CSL Limited Latest Developments

Table 97. Takeda Basic Information, Recombinant Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 98. Takeda Recombinant Plasma Protein Therapeutics Product Offered

Table 99. Takeda Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Takeda Main Business

Table 101. Takeda Latest Developments

Table 102. Octapharma Basic Information, Recombinant Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 103. Octapharma Recombinant Plasma Protein Therapeutics Product Offered

Table 104. Octapharma Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Octapharma Main Business

Table 106. Octapharma Latest Developments

Table 107. Novo Nordisk A/S Basic Information, Recombinant Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 108. Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Product Offered

Table 109. Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Novo Nordisk A/S Main Business

Table 111. Novo Nordisk A/S Latest Developments

Table 112. Pfizer Basic Information, Recombinant Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 113. Pfizer Recombinant Plasma Protein Therapeutics Product Offered

Table 114. Pfizer Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Pfizer Main Business

Table 116. Pfizer Latest Developments

Table 117. Bioverativ Therapeutics Basic Information, Recombinant Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 118. Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Product Offered

Table 119. Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Bioverativ Therapeutics Main Business

Table 121. Bioverativ Therapeutics Latest Developments

Table 122. Aptevo Therapeutics Basic Information, Recombinant Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 123. Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Product Offered

Table 124. Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Aptevo Therapeutics Main Business

Table 126. Aptevo Therapeutics Latest Developments

Table 127. Pharming Group Basic Information, Recombinant Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 128. Pharming Group Recombinant Plasma Protein Therapeutics Product Offered

Table 129. Pharming Group Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Pharming Group Main Business

Table 131. Pharming Group Latest Developments

List of Figures

Figure 1. Picture of Recombinant Plasma Protein Therapeutics

Figure 2. Recombinant Plasma Protein Therapeutics Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Recombinant Plasma Protein Therapeutics Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Recombinant Plasma Protein Therapeutics Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Recombinant Plasma Protein Therapeutics Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Recombinant Coagulation Factors

Figure 10. Product Picture of Human C1 Esterase Inhibitor

Figure 11. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Type in 2021

Figure 12. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Type (2017-2022)

Figure 13. Recombinant Plasma Protein Therapeutics Consumed in Hemophilia A

Figure 14. Global Recombinant Plasma Protein Therapeutics Market: Hemophilia A (2017-2022) & (K Units)

Figure 15. Recombinant Plasma Protein Therapeutics Consumed in Hemophilia B

Figure 16. Global Recombinant Plasma Protein Therapeutics Market: Hemophilia B (2017-2022) & (K Units)

Figure 17. Recombinant Plasma Protein Therapeutics Consumed in Von Willebrand Disease

Figure 18. Global Recombinant Plasma Protein Therapeutics Market: Von Willebrand Disease (2017-2022) & (K Units)

Figure 19. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)

Figure 20. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Application in 2021

Figure 21. Recombinant Plasma Protein Therapeutics Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Company in 2021

Figure 23. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Geographic Region in 2021

Figure 25. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Region (2017-2022)

Figure 26. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Country/Region in 2021

Figure 27. Americas Recombinant Plasma Protein Therapeutics Sales 2017-2022 (K Units)

Figure 28. Americas Recombinant Plasma Protein Therapeutics Revenue 2017-2022 ($ Millions)

Figure 29. APAC Recombinant Plasma Protein Therapeutics Sales 2017-2022 (K Units)

Figure 30. APAC Recombinant Plasma Protein Therapeutics Revenue 2017-2022 ($ Millions)

Figure 31. Europe Recombinant Plasma Protein Therapeutics Sales 2017-2022 (K Units)

Figure 32. Europe Recombinant Plasma Protein Therapeutics Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Recombinant Plasma Protein Therapeutics Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Recombinant Plasma Protein Therapeutics Revenue 2017-2022 ($ Millions)

Figure 35. Americas Recombinant Plasma Protein Therapeutics Sales Market Share by Country in 2021

Figure 36. Americas Recombinant Plasma Protein Therapeutics Revenue Market Share by Country in 2021

Figure 37. United States Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Recombinant Plasma Protein Therapeutics Sales Market Share by Region in 2021

Figure 42. APAC Recombinant Plasma Protein Therapeutics Revenue Market Share by Regions in 2021

Figure 43. China Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Recombinant Plasma Protein Therapeutics Sales Market Share by Country in 2021

Figure 50. Europe Recombinant Plasma Protein Therapeutics Revenue Market Share by Country in 2021

Figure 51. Germany Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Recombinant Plasma Protein Therapeutics Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Recombinant Plasma Protein Therapeutics Revenue Market Share by Country in 2021

Figure 58. Egypt Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Recombinant Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Recombinant Plasma Protein Therapeutics in 2021

Figure 64. Manufacturing Process Analysis of Recombinant Plasma Protein Therapeutics

Figure 65. Industry Chain Structure of Recombinant Plasma Protein Therapeutics

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles